W-F substitutions in apomyoglobin increase the local flexibility of the N-terminal region causing amyloid aggregation: A H/D exchange study. by Infusini G et al.
Send Orders of Reprints at reprints@benthamscience.net 
898  Protein & Peptide Letters, 2013, 20, 898-904  
 
W-F Substitutions in Apomyoglobin Increase the Local Flexibility of the 
N-terminal Region Causing Amyloid Aggregation: A H/D Exchange Study 
Giuseppe Infusini2, Clara Iannuzzi1, SilviaVilasi1, Rosa Maritato1, Leila Birolo2, Daniela Pagnozzi2, 
Piero Pucci2, Gaetano Irace1, and Ivana Sirangelo1,* 
1
Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Via De Crecchio 7, 
80138 Naples, Italy; 
2
Department of Chemical Sciences, University of Naples “Federico II”, Complesso Monte S. 
Angelo, Naples, Italy 
Abstract: Myoglobin is an -helical globular protein containing two highly conserved tryptophanyl residues at positions 7 
and 14 in the N-terminal region. The simultaneous substitution of the two residues impairs the productive folding of the 
protein making the polypeptide chain highly prone to aggregate forming amyloid fibrils at physiological pH and room 
temperature. The role played by tryptophanyl residues in driving the productive folding process was investigated by pro-
viding structural details at low resolution of compact intermediate of three mutated apomyoglobins, i.e., W7F, W14F and 
the amyloid forming mutant W7FW14F.  
In particular, we followed the hydrogen/deuterium exchange rate of protein segments using proteolysis with pepsin fol-
lowed by mass spectrometry analysis. The results revealed significant differences in the N-terminal region, consisting in 
an alteration of the physico-chemical properties of the 7-11 segment for W7F and in an increase of local flexibility of 
the12-29 segment for W14F. In the double trypthophanyl substituted mutant, these effects are additive and impair the 
formation of native-like contacts and favour inter-chain interactions leading to protein aggregation and amyloid formation 
at physiological pH. 
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INTRODUCTION 
 Protein misfolding and aggregation are central to the 
pathogenic mechanisms of several major human neurode-
generative diseases, including Alzheimer's disease, 
Creutzfeldt-Jakob disease, Huntington's disease, Parkinson's 
disease, type II diabetes, and Amyotrophic Lateral Sclerosis 
[1-6]. These diseases involve the formation of amyloid, a 
specific type of protein aggregate with a number of well de-
fined features. These include long, unbranched fibrils 5-10 
nm in diameter, a -rich circular dichroism spectrum, an X-
ray fiber diffraction pattern indicative of cross--structure in 
which -strands run perpendicular to the fibril axis, and a 
strong affinity for the Congo red dye [7, 8]. The proteins 
forming aggregates in pathological conditions do not share 
any sequence identity or structural homology to each other. 
Considerable heterogeneity also exists in secondary structure 
composition or chain length. Moreover, it has been observed 
that formation of fibrils is not a feature limited to a few pro-
teins or peptides associated with disease, but is a common 
characteristic of polypeptide chains. In fact, an increasing 
number of peptides and proteins unrelated to any pathologi-
cal condition have been found to form similar structures in 
vitro, under selected and appropriate conditions [9-14]. Such  
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a property arises from the intrinsic tendency of polypeptide 
chains to self-organize into polymeric assemblies that are 
stabilized by inter-molecular hydrogen bonds established 
between the peptide bonds of parallel or anti-parallel poly-
peptide stretches in -strand conformation. In this respect, 
natural proteins can be regarded as amino acid polymers 
selected by evolution so that their amino acid sequences are 
optimized to disfavour aggregation whilst favouring folding 
into compact, yet not rigid, states. This is mainly due to terti-
ary interactions among the side chains that shield not only 
the hydrophobic core but also the peptide backbone [15]. 
Conversely, protein aggregation into amyloid polymers, 
which are mainly stabilized by secondary interactions, can be 
considered the result of the emergence, under non-natural 
conditions, of the intrinsic primordial tendency of the peptide 
backbone to give secondary intermolecular interactions [9, 
15, 16]. Recent high-resolution structural studies have pro-
vided insights into this process [17-20]. A number of phys-
icochemical parameters of the polypeptide chain affect simi-
larly both protein folding and aggregation; these include a 
significant propensity to gain secondary structure, a low net 
charge and a relatively high content of hydrophobic residues 
[21]. Mutations neutral to the thermodynamic stability but 
increasing the mean hydrophobicity and the propensity to 
undergo local unfolding events or able to reduce the net 
charge can favour aggregation from the unfolded states in 
dynamic equilibrium with the folded structure [21]. Thus, 
protein folding and protein aggregation are considered dis-
 1875-5305/13 $58.00+.00 © 2013 Bentham Science Publishers 
W-F Substitutions in Apomyoglobin Protein & Peptide Letters, 2013, Vol. 20, No. 8   899 
tinct but competing processes, and the environmental condi-
tions dictate which one is favoured for a given polypeptide 
chain [22]. 
 The target protein of this work is apomyoglobin 
(apoMb), a well-characterized all -helical single domain 
protein whose full length chain folding pathways have been 
well-studied [23-27]. The apoMb folding proceeds through 
compact intermediates that have been detected in both ki-
netic and equilibrium experiments. In most of these interme-
diates, A, G, and H helices are folded and sterically oriented 
as in the native AGH subdomain, whereas the remainder of 
the molecule seems to be unordered [28-33]. Although not 
involved in any amyloid disease, myoglobin is able to aggre-
gate and form amyloid fibrils under appropriate experimental 
conditions [34]. Moreover, the replacement of both indole 
residues located at positions 7 and 14 in the N-terminal re-
gion of the protein with phenylalanine residues, i.e. W7F/ 
W14F, renders the protein highly susceptible to aggregation 
and formation of amyloid fibrils under experimental condi-
tions not drastically different from the natural setting (pH 7.0 
and room temperature) [35, 36]. The ability to aggregate has 
been related to the increased hydrophobicity of the N-
terminal segment of apomyoglobin and to the increased ag-
gregation propensity caused by W-F substitutions [36]. The 
aggregation process starts from a native-like globular state 
able to bind the prosthetic group with spectroscopic proper-
ties similar to those observed for wild-type apoprotein. Nev-
ertheless, the protein rapidly aggregates, forming oligomeric 
species that slowly convert into proto-fibrils and mature 
amyloid fibrils [37, 38]. The structure of amyloid fibrils 
formed by W7F/W14F apoMb has been studied by a battery 
of biophysical techniques. The rigid core of amyloid fibrils 
of apoMb includes A, B, E, and part of D and G helices, i.e., 
not only the N-terminal region but also the molecular regions 
which form the binding site for the prosthetic group in the 
native globular state [37, 39]. Studies performed with deleted 
and circularly permuted mutations on sperm whale myoglo-
bin strongly highlight that the native position of the N-
terminus is important for the precise structural architecture 
of the protein [40]. The apo form of the deleted and per-
muted mutants show native-like folding and bind heme, but 
is less stable and exhibits a stronger tendency to aggregate. 
Moreover, the circularly permuted mutants form cytotoxic 
fibrils at a rate higher than wild type [41]. 
 We recently reported that the W-F substitutions at posi-
tion 7 and 14 differently affect the structural organization 
and dynamics of the AGH subdomain of apomyoglobin. The 
combined effect of the two substitutions in the double mu-
tant determines further changes that make the polypeptide 
chain more susceptible to aggregation and amyloid formation 
[39]. These considerations prompted us to investigate how 
the single substitution W-F at either position 7 or 14 affects 
the flexibility of the protein. We followed the hydro-
gen/deuterium exchange rate of the different protein seg-
ments using proteolysis with pepsin followed by mass spec-
trometry. Differently deuterated peptide fragments reflect the 
different flexibility of the various protein regions. Mass 
spectrometry analysis has been recently used to unravel mo-
lecular details for other amyloid proteins as well [42, 43]. 
We focused our attention on the local flexibility properties of  
 
the compact intermediate state predominantly populated at 
pH 4.0, since it represents the early organized structure from 
which the native apomyoglobin fold originates [23, 44-46]. 
The behaviour of single W-F mutants (W7F and W14F) at 
pH 4.0 was compared with that of the amyloid-forming dou-
ble mutant (W7FW14F) at pH 4.0, a pH value at which it is 
soluble without any tendency to aggregate, since aggregation 
occurs only when the pH is raised from 4.0 to neutrality [35, 
36]. The results show that the W - F substitutions at positions 
7 or 14 differently affect the flexibility and structural organi-
zation of the segment 7-11 in W7F and the segment 12-29 in 
W14F. The combination of the two effects in the double mu-
tant may certainly contribute to explain the high propensity 
to aggregate in amyloid fibrils and further corroborates the 
influence of the N-terminal region in stabilizing the native 
fold.  
MATERIALS AND METHODS 
Protein Expression and Purification 
 Wild type sperm whale myoglobin was obtained express-
ing the synthetic gene in Escherichia coli strain TB-1 [ara,  
(lac-pro), strA, thi, 80dlacZM, r-, m+] [47]. The tryp-
tophanyl substitutions were performed as described else-
where [48]. Wild type, W7F and W14F mutants were essen-
tially purified as described by Springer and Sliger [47]. The 
culture was grown at 37°C in Luria-Bertrani broth in the 
presence of ampicillin (200 mg/L), harvested in the late log 
phase, lysed in lysis buffer (50 mM Tris.HCl, 1.0 mM 
EDTA, 0.5 mM DTT, 40 units of DNase per mL, 3 units of 
RNase A per mL, 4 mg of lysozyme per mL, pH 8.0) at 4°C 
overnight, and sonicated for 30 min on ice. Cell debris was 
removed by centrifugation, and the supernatant was fraction-
ated by ammonium sulphate precipitation. The 60-95% cut 
was centrifuged and suspended in 20 mM Tris and 1.0 mM 
EDTA (pH 8.0) and fractionated on a Sephadex G-50 
(Pharmacia) gel filtration column (2.5 x 100 cm) equilibrated 
in the same buffer. Fractions containing reddish-brown myo-
globin were collected and applied to a Whatman DEAE 52 
ion exchange column (2.5 x 20 cm) equilibrated and resolved 
with 20 mM Tris.HCl (pH 8.4). Under these conditions the 
myoglobin did not stick on the column and was rapidly 
eluted. Protein purity was controlled by sodium dodecyl sul-
phate-polyacrylamide gel electrophoresis [49]. The heme 
was removed from myoglobin by the 2-butanone extraction 
procedure [50]. The contamination of the apoprotein by my-
oglobin was assessed spectrophotometrically. In all cases, no 
significant absorption was observed in the Soret region. 
W7FW14F myoglobin mutant was purified as N-terminal 
His-tagged form via affinity chromatography on Ni2+-
nitrilotriacetic acid resin [35, 36]. 
 Protein concentration was determined under denaturing 
conditions measuring absorption at 280 nm for wild type, 
W7F and W14F mutants and at 275 nm for W7FW14F mu-
tant. The molar extinction coefficients, calculated from the 
tryptophan and tyrosine content [51, 52] were 280 = 13500, 
and 9750 M-1 cm-1 for wild type and single tryptophanyl sub-
stituted myoglobins respectively and 275 = 3750 M-1 cm-1 for 
W7FW14F mutant. The absorption measurements were car-
ried out on a Jasco V-550 spectrophotometer [53]. 
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H/D Exchange 
 The H/D exchange reaction was conducted as follows: 
the protein sample (4 pmol/μL) was allowed to equilibrate 
for 15 min at 25°C in appropriate buffer (ammonium acetate 
10 mM, pH 7.0 or pH 4.0). Deuterium exchange was initi-
ated at 25°C by 5-fold dilution with ammonium acetate 10 
mM in D2O, at the appropriate pD. At various exchange 
times (15 sec. to 1h), ~ 5 nmol of protein were removed from 
the labelling solution, and rapidly injected into a 30 x 0.46 
mm i.d. reverse-phase perfusion column (POROS 10 R2, 
Applied Biosystems) coupled to a ZQ single quadrupole in-
strument (Micromass) (3.8 kV capillary voltage, 40 V cone 
voltage, 80°C source and desolvation temperature). The pro-
tein was eluted at a flow rate of 0.5 mL/min with a 10-60% 
CH3CN gradient in 0.1% TFA in 1 min. The HPLC step was 
quickly performed with cold protiated solvents, keeping the 
column submerged in an ice-bath, thereby reducing the back-
exchange kinetics while removing deuterium from side 
chains and amino/carboxy termini that exchange much faster 
than amide linkages [54]. The increase in molecular mass of 
the protein sample then constituted a direct measurement of 
deuterium incorporation at peptide amide linkages. Duplicate 
analyses were performed for each time point. Data were ac-
quired and elaborated using the Biomultiviewer (Applied 
Biosystems) program and reported as percentage of ex-
changed protons, considering the number of non-proline 
residues in the protein.  
 Pepsin digestion of protein deuterated samples (see 
above), was performed by 4-fold dilution of each sample (2 
nmol) with a 0.1% TFA (pH 2.5) containing pepsin (3.5/1 
w/w enzyme/substrate ratio) and incubating for 5 min at 0°C. 
Peptides were analysed by LC-ESMS on a ZQ instrument 
coupled to a 2690 Alliance HPLC, Waters using a 30 x 2.1 
mm i.d. C-18 reverse-phase column (X-TERRA, Waters). 
Peptides were eluted at a flow rate of 0.2 mL/min with a 10-
60% CH3CN gradient in 0.1% TFA in 8 min. HPLC solvents 
and column were kept ice-cold in a bath. Mass spectrometry 
data were obtained, elaborated, and reported as above de-
scribed. Non-deuterated samples (2 nmol) were digested 
with pepsin as above and fractionated using a 250 x 2.1 nm, 
300 Å Phenomenex Jupiter C18 column on a HP 1100 HPLC 
(Agilent Technologies) coupled to a LCQ ion trap (Finnigan 
Corp.) in order to confirm peptide assignments by MS/MS 
analysis.  
RESULTS AND DISCUSSION 
Hydrogen-Deuterium Exchange Analyses of Intact Pro-
teins 
 Comparative hydrogen-deuterium exchange experiments 
were carried out on wild type apomyoglobin and W7F, 
W14F and W7FW14F mutants. Proteins were diluted in the 
appropriate D2O buffers at different interval times and, then, 
analyzed by fast LC-ESMS. Since protein terminal groups 
and side chains rapidly back-exchange deuterium during the 
LC step, the increase in the molecular mass measured by MS 
is only related to the number of deuterium atoms incorpo-
rated in the protein backbone. The single envelope of isotope 
peaks occurring in the mass spectra of the species indicated  
 
an EX2 kinetics of hydrogen-deuterium exchange [54], con-
firming that the examined protein species are homogeneous 
and stable. 
 The experimental molecular mass for the non deuterated 
species are in full agreement with the mass calculated on the 
basis of the aminoacidic sequences. The 100% reference 
sample consisting of fully deuterated proteins was calculated 
considering the number of non-proline residues. The per-
centage of deuterium incorporation was calculated at each 
incubation time in deuterated buffer (from 0 to 60 min) by 
considering the mass increase and the 100% reference spe-
cies. Fig. 1a shows the kinetics of H/D exchange of the intact 
soluble apoproteins (wild type, W7F, and W14F) at pH 7.0; 
at this pH the double mutant is insoluble, thus impairing the 
analysis on W7FW14F. Raw data were corrected for back-
exchange and plotted as percentage of exchanged protons as 
a function of time. Data reported are the average over three 
independent experiments. Following 60 min of reaction, H/D 
exchange revealed that wild type protein incorporated 61 ± 1 
deuterium atoms. The extent of protons exchanged by wild 
type apomyoglobin, corresponding to about 40%, is consis-
tent with a structured and homogeneously compact protein, 
in agreement with data previously reported on apomyoglo-
bins [32, 55]. The two W7F and W14F mutants showed a 
similar behaviour with a total of 85 ± 2 hydrogen atoms re-
placed by deuterium, corresponding to about 55% of the to-
tal. The 15% increase in deuterium incorporation in the sin-
gle mutants with respect to wild type apomyoglobin indi-
cates a more flexible conformation, in agreement with fluo-
rescence quenching data previously reported [39]. 
 The time course of H/D exchange for wt, W7F, W14F 
and W7FW14F intermediates at pH 4.0 is reported in Fig. 
1b. Following 60 min of reaction, when the equilibrium was 
attained, the wild type protein showed a higher extent of 
deuterium incorporation as compared to the equilibrium 
value reached at pH 7.0, with a total of 55% hydrogen atoms 
exchanged. The increase in deuterium content is consistent 
with the partial unfolding of the protein at acidic pH to gen-
erate the compact intermediate state; however, a significant 
amount of secondary and tertiary structure should be still 
retained, since about 45% of the amide protons are shielded 
to the solvent. A smaller increase of H/D exchange was ob-
served at pH 4.0 for single mutants with respect to native 
proteins, i.e., 60% vs 55%. This suggests the occurrence of 
only a moderate unfolding in passing from the native state to 
the corresponding partially folded intermediate forms. The 
incorporation of deuterium of the double mutant W7FW14F 
at pH 4.0 is shown in Fig. 1b. The exchanging profiles of 
single and double mutants were almost superimposable, with 
only a slightly faster incorporation observed for the 
W7FW14F mutant. These data show that the compact inter-
mediate formed at pH 4.0 by mutant apomyoglobins still 
consists of a largely structured and compact protein region 
with a definite degree of conformational flexibility, suggest-
ing the presence of an organized AGH domain analogous to 
the wild-type protein.  
 However, this subdomain in W7FW14F mutant seems to 
be slightly more flexible as compared to W7F and W14F 
apoMbs. 
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Figure 1. Hydrogen-exchange kinetic profiles of wild type (, blue 
line), W7F (, green line), W14F (, pink line) at pH 7.0 (a) and 
pH 4.0 (b), and W7FW14F (, red line) at pH 4.0 (b) apomyoglo-
bins. The number of exchanged protons at each incubation time was 
determined from the centroid of the isotopic envelopes, averaged 
and corrected with reference samples. 
Flexibility of Protein Regions in the Intermediate State 
 The differences occurring among the compact intermedi-
ates of the apomyoglobin mutants were further investigated 
by proteolytic digestion with pepsin of the deuterated pro-
teins carried out at acidic pH. Wild-type apomyoglobin, 
W7F, W14F and W7F/W14F were equilibrated at pH 4.0 and 
then allowed to exchange for various times before digestion 
with pepsin under H/D quenching conditions (0°C, pH 2.5). 
The digested peptide mixtures were directly analysed by fast 
LC-ESMS, and data were corrected for back-exchange. Pep-
tic fragments were identified by their unique mass values and 
MS/MS sequence analyses. Several different peptides corre-
sponding to the same protein regions were observed in the 
digest due to the rather broad specificity of pepsin. The non-
redundant series of the shortest peptides covering nearly the 
entire protein sequence was then considered in the analysis 
(Fig. 2).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Sperm whale myoglobin sequence. Secondary structure 
elements are boxed on the sequence and the helices A-H are indi-
cated. Fragments produced by peptic digestion are shown below the 
sequence. 
 
 Fig. 3 shows the percentage of H/D exchange for each 
selected fragment as a function of D2O labeling time of the 
intact proteins. No substantial differences were observed in 
most of the fragments, i.e. peptides 33-55, 56-69, 70-106, 
110-137 and 138-153, encompassing almost the entire pro-
tein sequence. However, significant differences in the ex-
change properties could be detected in the N-terminal region 
of the intermediates. The double tryptophanyl mutant exhib-
ited a much higher degree of deuterium incorporation than 
the wild type, particularly in the fragment 12-29, where one 
of the mutations had occurred. This indicates that the differ-
ences in conformational flexibility between the compact in-
termediate of the double mutant and the wild type are local-
ised within the N-terminal region. The deuteration profile of 
the 12-29 fragment in the W7F mutant was very similar to 
that displayed by the wild type protein, whereas the W14F 
mutant exhibited a higher degree of deuterium incorporation, 
almost identical to the W7FW14F protein. These data sug-
gest that replacement of W14 with phenylalanine resulted in 
higher flexibility of the closely surrounding protein region. 
Moreover, the results reported in Fig. 3 clearly indicate that 
the physico-chemical properties of the N-terminal end of the 
protein are heavily affected by the presence of a phenyla-
lanine residue at position 7. In fact, the fragment 7-11 could 
not be detected either in W7F or in W7FW14F apomyoglo-
bins. A plausible explanation might be the increased ten-
dency of this fragment to aggregate, although an influence of 
the substitution on pepsin selectivity cannot be ruled out. 
However, the lack of any new peptides in pepsin digestion 
compared to wild type that might account for the presence of 
the segment 7-11 in the longer peptide, support the possibil-
ity that aggregation occurred. Chow et al. [56] reported that 
the 1-36 N-terminal fragment of wild type apomyoglobin 
displays a high level of ß-structure and forms macroscopic 
aggregates when the pH gets closer to neutrality. The WF 
substitution at position 7 certainly contributes to increase the 
hydrophobicity of the 7-11 fragment, thus favouring aggre-
gation. This result further suggests that the W-F replacement 
in position 7 could induce local unfolding events which trig-
ger the  -  transition responsible for amyloid aggregation 
[39]. It is worth mentioning that the exchange behaviour of 
the 7-11 peptide in the wild type apomyoglobin and W14F  
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mutant was quite dissimilar, although in this region the two 
protein species exhibit the same amino acid sequence. This 
suggests that tryptophanyl substitution in position 14 also 
affects the flexibility of the adjacent peptide region. 
 We have previously shown that the simultaneous W-F 
substitution has a dramatic effect on the structure and flexi-
bility of the apoMb molecule [39]. In particular, the tryp-
tophanyl substitution at position 7 changes the secondary 
organization of the folded portion of the compact intermedi-
ate, which in turn alters the interaction between the AGH 
subdomain and the remainder of the molecule, perturbing the 
docking of AGH core and E helix [39]. The other substitu-
tion has a less marked effect on secondary structure but a 
higher effect on the local conformational flexibility. The data 
reported in this paper corroborate this picture. Moreover, 
these data further underline the importance of the N-terminal 
region in stabilizing the precise structural architecture of 
myoglobin [40, 41].  
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Figure 3. Hydrogen-exchange kinetic profiles of peptides generated by peptic digestion of wild type (, blue line), W7F (, green line), 
W14F (, pink line), W7FW14F (, red line) apomyoglobins deuterated at pH 4.0. The number of protons exchanged at each time was de-
termined from the centroid of the isotopic envelopes, averaged and corrected with reference samples. 
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